82 related articles for article (PubMed ID: 16934800)
21. KLF11 promotes the proliferation of breast cancer cells by inhibiting p53-MDM2 signaling.
Hou ZH; Tao M; Dong J; Qiu HM; Li F; Bai XY
Cell Signal; 2024 May; 120():111238. PubMed ID: 38810862
[TBL] [Abstract][Full Text] [Related]
22. The Role of E3 Ligase Pirh2 in Disease.
Daks A; Fedorova O; Parfenyev S; Nevzorov I; Shuvalov O; Barlev NA
Cells; 2022 Apr; 11(9):. PubMed ID: 35563824
[TBL] [Abstract][Full Text] [Related]
23. Targeting Post-Translational Modifications of the p73 Protein: A Promising Therapeutic Strategy for Tumors.
Omran Z; H Dalhat M; Abdullah O; Kaleem M; Hosawi S; A Al-Abbasi F; Wu W; Choudhry H; Alhosin M
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33921128
[TBL] [Abstract][Full Text] [Related]
24. Regulation of p53 by E3s.
Pan M; Blattner C
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33670160
[TBL] [Abstract][Full Text] [Related]
25. Regulation of the p53 Family Proteins by the Ubiquitin Proteasomal Pathway.
Bang S; Kaur S; Kurokawa M
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905981
[TBL] [Abstract][Full Text] [Related]
26. Residues 240-250 in the C-terminus of the Pirh2 protein complement the function of the RING domain in self-ubiquitination of the Pirh2 protein.
Abou Zeinab R; Wu H; Sergi C; Leng RP
PLoS One; 2013; 8(12):e82803. PubMed ID: 24367557
[TBL] [Abstract][Full Text] [Related]
27. Role of E3 ubiquitin ligases in lung cancer.
Snoek BC; de Wilt LH; Jansen G; Peters GJ
World J Clin Oncol; 2013 Aug; 4(3):58-69. PubMed ID: 23936758
[TBL] [Abstract][Full Text] [Related]
28. p28, a first in class peptide inhibitor of cop1 binding to p53.
Yamada T; Christov K; Shilkaitis A; Bratescu L; Green A; Santini S; Bizzarri AR; Cannistraro S; Gupta TK; Beattie CW
Br J Cancer; 2013 Jun; 108(12):2495-504. PubMed ID: 23736031
[TBL] [Abstract][Full Text] [Related]
29. SCY1-like 1 binding protein 1 (SCYL1-bp1) interacts with p53-induced RING H2 protein (Pirh2) after traumatic brain injury in rats.
Chen J; Zou F; Fu H; Mao H; Gong M; Ni L; Xu X; Shi J; Ke K; Cao M; Zhou F; Shi W
J Mol Histol; 2013 Jun; 44(3):271-83. PubMed ID: 23479292
[TBL] [Abstract][Full Text] [Related]
30. Pirh2 E3 ubiquitin ligase modulates keratinocyte differentiation through p63.
Jung YS; Qian Y; Yan W; Chen X
J Invest Dermatol; 2013 May; 133(5):1178-87. PubMed ID: 23235527
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical detection of P53 and Mdm2 in vitiligo.
Bakry OA; Hammam MA; Wahed MM
Indian Dermatol Online J; 2012 Sep; 3(3):171-6. PubMed ID: 23189248
[TBL] [Abstract][Full Text] [Related]
32. It Takes 15 to Tango: Making Sense of the Many Ubiquitin Ligases of p53.
Love IM; Grossman SR
Genes Cancer; 2012 Mar; 3(3-4):249-63. PubMed ID: 23150758
[TBL] [Abstract][Full Text] [Related]
33. SCYL1BP1 modulates neurite outgrowth and regeneration by regulating the Mdm2/p53 pathway.
Liu Y; Chen Y; Lu X; Wang Y; Duan Y; Cheng C; Shen A
Mol Biol Cell; 2012 Dec; 23(23):4506-14. PubMed ID: 23051735
[TBL] [Abstract][Full Text] [Related]
34. Proteomic analysis of Terminalia chebula extract-dependent changes in human lymphoblastic T cell protein expression.
Das ND; Jung KH; Park JH; Choi MR; Lee HT; Kim MS; Lee SR; Chai YG
J Med Food; 2012 Jul; 15(7):651-7. PubMed ID: 22471968
[TBL] [Abstract][Full Text] [Related]
35. The p73 tumor suppressor is targeted by Pirh2 RING finger E3 ubiquitin ligase for the proteasome-dependent degradation.
Jung YS; Qian Y; Chen X
J Biol Chem; 2011 Oct; 286(41):35388-35395. PubMed ID: 21852228
[TBL] [Abstract][Full Text] [Related]
36. Structural and functional comparison of the RING domains of two p53 E3 ligases, Mdm2 and Pirh2.
Shloush J; Vlassov JE; Engson I; Duan S; Saridakis V; Dhe-Paganon S; Raught B; Sheng Y; Arrowsmith CH
J Biol Chem; 2011 Feb; 286(6):4796-808. PubMed ID: 21084285
[TBL] [Abstract][Full Text] [Related]
37. A newly identified Pirh2 substrate SCYL1-BP1 can bind to MDM2 and accelerate MDM2 self-ubiquitination.
Yan J; Zhang D; Di Y; Shi H; Rao H; Huo K
FEBS Lett; 2010 Aug; 584(15):3275-8. PubMed ID: 20598683
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-34a is an important component of PRIMA-1-induced apoptotic network in human lung cancer cells.
Duan W; Gao L; Wu X; Wang L; Nana-Sinkam SP; Otterson GA; Villalona-Calero MA
Int J Cancer; 2010 Jul; 127(2):313-20. PubMed ID: 19921694
[TBL] [Abstract][Full Text] [Related]
39. The expression of COX-2, hTERT, MDM2, LATS2 and S100A2 in different types of non-small cell lung cancer (NSCLC).
Strazisar M; Mlakar V; Glavac D
Cell Mol Biol Lett; 2009; 14(3):442-56. PubMed ID: 19238334
[TBL] [Abstract][Full Text] [Related]
40. Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor.
Chiou SH; Kao CL; Chen YW; Chien CS; Hung SC; Lo JF; Chen YJ; Ku HH; Hsu MT; Wong TT
PLoS One; 2008 May; 3(5):e2090. PubMed ID: 18509505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
